Associations of obesity, systemic inflammation, and hyperinsulinemia with the incidence of non‐communicable chronic disease and mortality: A prospective cohort study
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70568 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Natasha Wiebe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Hyperinsulinism, Obesity, Inflammation, Noncommunicable Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cumming School of Medicine, University of Calgary.
Abstract (Originalsprache)
Aims
Obesity, systemic inflammation, and hyperinsulinemia are all features of metabolic syndrome and frequently occur together. We aimed to evaluate the association of body mass index (BMI) with incident non‐communicable chronic disease (NCD) or all‐cause mortality, independent of C‐reactive protein (CRP) and fasting insulin.
Methods
This prospective population‐representative cohort included Canadian residents aged ≥18 years from the Canadian Health Measure Survey. The exposures were BMI, CRP, and fasting insulin and the outcomes were mortality and incident NCDs. Results were externally validated using data from the United States (NHANES) and the United Kingdom (UK Biobank). We report hazards ratios (HRs) from Cox models using percentiles for the continuous exposures: 99th, 95th, 85th, 50th, 15th, 1st versus the 5th percentile. The fifth percentile for BMI was 19.6 kg/m 2 , which falls within the “healthy” range.
Results
Of ~8280 participants: 24.4% had obesity (BMI ≥30 kg/m 2 ), 56.5% had inflammation (CRP >1 mg/L), and 36.6% had hyperinsulinemia (fasting insulin >75 pmol/L). Metabolic syndrome (≥1 feature) was more common without obesity (42.8%; ~3544 participants) than with obesity (22.9%; ~1896 participants). Participants were followed for a median of 6.7 years; 3.1% died and 7.4% developed an NCD (including 1.8% with cardiovascular disease). After adjustment for age, sex and smoking, CRP was positively associated with mortality (HR vs. referent for 1st and 99th %ile: 0.72 [95% confidence interval, CI 0.61, 0.84] and 7.67 [95% CI 2.89, 20.38]), as was fasting insulin (0.88 [95% CI 0.78, 0.99] and 3.22 [95% CI 1.12, 9.29] respectively). BMI was negatively associated with mortality (HR vs. referent for 1st and 95th %ile: 1.45 [95% CI 1.11, 1.88] and 0.46 [95% CI 0.22, 0.97]), although HR for the 99th %ile was non‐significant (0.51 [95% CI 0.20, 1.27]). All three exposures were mostly positively associated with incident NCD but varied depending on the type of NCD.
Conclusions
After adjustment for confounding by systemic inflammation and hyperinsulinemia, obesity was associated with a lower risk of death but with a higher risk of incident NCD. As there are more people with metabolic syndrome without obesity than with obesity, future research should prioritise the study of how to best diagnose, monitor and treat inflammation and hyperinsulinemia rather than obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Department of Clinical Science, Karolinska Institutet, Stockholm, Sweden.
- Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: Natasha Wiebe
Förderung
- Cumming School of Medicine, University of Calgary
Zitieren
APA
Wiebe, N., Thompson, S., Stenvinkel, P., Bello, A., James, M. T., & Tonelli, M. (2026). Associations of obesity, systemic inflammation, and hyperinsulinemia with the incidence of non‐communicable chronic disease and mortality: A prospective cohort study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70568
Vancouver
Wiebe N, Thompson S, Stenvinkel P, Bello A, James MT, Tonelli M. Associations of obesity, systemic inflammation, and hyperinsulinemia with the incidence of non‐communicable chronic disease and mortality: A prospective cohort study. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70568
BibTeX
@article{Wiebe2026,
author = {Wiebe, Natasha and Thompson, Stephanie and Stenvinkel, Peter and Bello, Aminu and James, Matthew T and Tonelli, Marcello},
title = {Associations of obesity, systemic inflammation, and hyperinsulinemia with the incidence of non‐communicable chronic disease and mortality: A prospective cohort study},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70568}
}
EUVIMED